Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc.CDIO · Entity 8239 | Chief Technology Officer | September 06, 2024 | October 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardio Diagnostics Holdings, Inc.
Report date September 06, 2024 · Filed October 09, 2024 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 197,310 |
Reported balance
After 2024-09-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2024-09-06 · Purchase · Acquired 68,965 · Balance 197,310 F1: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F2: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship.
F2: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2024 Filed Sep 23, 2024 20:24 UTC Amendment | Cardio Diagnostics Holdings, Inc. NUTX · Entity 8239 | PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000047 · primary_doc.xml · nonDerivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,310 F1 · shares: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer. Read SEC document |
| September 06, 2024 Filed Oct 9, 2024 17:18 UTC Amendment | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | PurchaseCommon Stock | 68,965 | $0.29 | $19,999.85 |
DisclosureSEC source: 0001486189-24-000050 · primary_doc.xml · nonDerivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,310 F1 · shares: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F1 · balance_after: The reporting person holds the shares in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship. F2 · ownership.direct: The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer. Read SEC document |
| January 23, 2024 Filed Feb 21, 2024 19:59 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 476,256 | $2.11 Strike: $2.11 | $1,004,900.16 |
DisclosureSEC source: 0001486189-24-000010 · primary_doc.xml · derivative · entry 2 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (1) Disclosed balance after: 1,433,958 Underlying: Common Stock · 476,256 shares Expires 2034-01-23 F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein. Read SEC document |
| January 23, 2024 Filed Feb 21, 2024 19:59 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 238,128 | $2.11 Strike: $2.11 | $502,450.08 |
DisclosureSEC source: 0001486189-24-000010 · primary_doc.xml · derivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,467 Underlying: Common Stock · 238,128 shares Expires 2034-01-23 Read SEC document |
| August 31, 2023 Filed Sep 8, 2023 16:12 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | PurchaseCommon Stock | 16,481 | $0.55 | $8,982.15 |
DisclosureSEC source: 0001486189-23-000026 · primary_doc.xml · nonDerivative · entry 2 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,345 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. Read SEC document |
| August 25, 2023 Filed Sep 8, 2023 16:12 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | PurchaseCommon Stock | 1,770 | $0.56 | $982.35 |
DisclosureSEC source: 0001486189-23-000026 · primary_doc.xml · nonDerivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,864 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:59 UTC | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 156,750 | $1.26 Strike: $1.26 | $197,505.00 |
DisclosureSEC source: 0001486189-23-000015 · primary_doc.xml · derivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,750 Underlying: Common Stock · 156,750 shares Expires 2033-06-23 Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 18:48 UTC Amendment | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 272,250 | $1.26 Strike: $1.26 | $343,035.00 |
DisclosureSEC source: 0001486189-23-000019 · primary_doc.xml · derivative · entry 2 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (1) Disclosed balance after: 272,250 Underlying: Common Stock · 272,250 shares Expires 2033-06-23 F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of his actual pecuniary interest therein. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 18:48 UTC Amendment | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 157,750 | $1.26 Strike: $1.26 | $198,765.00 |
DisclosureSEC source: 0001486189-23-000019 · primary_doc.xml · derivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,750 Underlying: Common Stock · 157,750 shares Expires 2033-06-23 Read SEC document |
| June 23, 2023 Filed Nov 3, 2023 19:56 UTC Amendment | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 272,250 | $1.26 Strike: $1.26 | $343,035.00 |
DisclosureSEC source: 0001486189-23-000039 · primary_doc.xml · derivative · entry 2 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See note (1) Disclosed balance after: 272,250 Underlying: Common Stock · 272,250 shares Expires 2033-06-23 F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of his actual pecuniary interest therein. Read SEC document |
| June 23, 2023 Filed Nov 3, 2023 19:56 UTC Amendment | Cardio Diagnostics Holdings, Inc. CDIO · Entity 8239 | GrantStock Options (Right to Buy) · Derivative | 156,750 | $1.26 Strike: $1.26 | $197,505.00 |
DisclosureSEC source: 0001486189-23-000039 · primary_doc.xml · derivative · entry 1 Dogan Timur · CIK 0001950663 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,750 Underlying: Common Stock · 156,750 shares Expires 2033-06-23 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.